Trader’s Buzz: Galmed Pharmaceuticals (GLMD), China Finance Online (JRJC), NQ Mobile (NQ), Nxt-ID, Inc. (NXTD)
September 23, 2014 at 13:28 PM EDT
Galmed Pharmaceuticals Ltd. (GLMD) gained $3.17, or 48%, to $9.56 in mid-day trading today following the company’s announcement that the FDA approved its request for Fast Track Designation of its product candidate, aramchol for the treatment of Non-Alcoholic Steato-Hepatitis, or NASH. Approximately 3,451,520 shares have already changed hands, compared to the stock’s average daily volume of […] View the full post at: Trader’s Buzz: Galmed Pharmaceuticals (GLMD), China Finance Online (JRJC), NQ Mobile (NQ), Nxt-ID, Inc. (NXTD) Related posts: Euro finance ministers to agree on Greek aid: source Feudal Lords Of Finance The Senate Finance Committee Rejects ‘Public Option’